Close

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells Abstract Background CD133-positive cells in hepatocellular carcinoma (HCC) display cancer